Role of Transforming Growth Factor-β1 and Smads Signaling Pathway in Intrauterine Adhesion
Table 4
Clinical and laboratory findings of the study groups.
Variable
IUA ()
Control ()
Clinical findings
Age
28.06 ± 3.63
28.43 ± 3.44
0.319
Normal menses
—
30
0
Hypomenorrhea
60
—
0
Cyclical lower abdominal pain
24
—
0
Abortion
60
—
0
Laboratory findings
RBC (10−12/L)
4.41 ± 0.28
4.42 ± 0.21
0.948
WBC (10−9/L)
5.38 ± 1.33
5.47 ± 0.83
0.748
Hb (g/L)
131.5 ± 7.79
133.13 ± 6.14
0.089
FSH (mlU/mL)
7.58 ± 1.76
8.18 ± 1.53
0.117
LH (mlU/mL)
7.64 ± 2.44
7.68 ± 1.67
0.209
PRL (ng/mL)
17.59 ± 2.95
16.57 ± 3.86
0.168
Estrogen (pmol/L)
277.25 ± 155.4
282.65 ± 121.91
0.868
Progesterone (0.ng/mL)
0.651 ± 1,02
0.822 ± 0.07
0.366
Testosterone (ng/dL)
28.76 ± 7.61
28.42 ± 5.82
0.831
The data are represented as mean ± SD. FSH = follicle stimulating hormone, LH = luteinizing hormone, and PRL = prolactin. All values are represented comparisons between IUA patient and control groups.